Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 75 out of 100. Cognitive tests and assessment

Topic: Brain imaging, connectivity and assessment

Plain-language summary

AD was characterized by longer time in bed, more bed exits, less snoring, and changes in estimated sleep states. We derived the Dementia Research Institute Sleep Index for Alzheimer's Disease (DRI-SI-AD), a digital biomarker quantifying sleep disturbances. DRI-SI-AD detected the effects of acute clinical events and dementia progression at the individual level. Our approach may help bridge a gap in dementia care by providing a zero-burden method for longitudinal monitoring of health events, disease progression, and dementia risk. HIGHLIGHTS: Continuous monitoring reveals dementia-specific nocturnal sleep disturbances. We developed a novel sleep biomarker, Dementia Research Institute Sleep Index (AD), for tracking Alzheimer's disease (AD) progression. We used contactless under-mattress sensors for low-burden, long-term data collection. Prolonged bedtimes and frequent exits were identified as key dementia-related sleep traits. We demonstrated the feasibility of in-home monitoring for dementia care and risk assessment.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Soreq, E., Kolanko, M. A., CRT group, Ravindran, K. K. G., Della Monica, C., Revell, V., et al. (2025). Contactless longitudinal monitoring in the home characterizes aging and Alzheimer's disease-related night-time behavior and physiology. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.70758

Vancouver

Soreq E, Kolanko MA, CRT group, Ravindran KKG, Della Monica C, Revell V, et al. Contactless longitudinal monitoring in the home characterizes aging and Alzheimer's disease-related night-time behavior and physiology. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025. doi:10.1002/alz.70758. PMID: 41137623.

BibTeX

@article{soreq2025-41137623,
  author  = {Soreq, Eyal and Kolanko, Magdalena A and {CRT group} and Ravindran, Kiran K G and Della Monica, Ciro and Revell, Victoria and Daniels, Sarah and Joffe, Anna and others},
  title   = {{Contactless longitudinal monitoring in the home characterizes aging and Alzheimer's disease-related night-time behavior and physiology}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70758},
  pmid    = {41137623},
  url     = {https://doi.org/10.1002/alz.70758}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Study details

How this study scored 75/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record left out, no data; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 4 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multicenter collaboration left out, no data; Indexed in PubMed 2 of 2; Free to read left out, no data. 42 of the 56 points it could be judged on, which is 75 of 100. Total 75 of 100.42 of the 56 points we could judge = 75 of 100

Published in a leading specialty journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 42 of the 56 points we could judge it on, which is 75 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Alzheimer's & dementia : the journal of the Alzheimer's Association)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 4 / 4 13,588 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multicenter collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41137623)
Free to read — / 2 Access not recorded — left out of this score
Points 42 / 56 Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 42 of the 56 points we could judge it on is 75 out of 100.
Total 75 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Studies in the library that share something with this one. The line above each title says what.

Related studies in Cognitive tests and assessment from nearby years

Also tagged “apnea”

196 studies in the library carry the topic tag “apnea”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 196 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Cognitive tests and assessment

See all studies in Cognitive tests and assessment →